chrX-120626865-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001011551.3(C1GALT1C1):c.302G>A(p.Ser101Asn) variant causes a missense change. The variant allele was found at a frequency of 0.00739 in 1,209,810 control chromosomes in the GnomAD database, including 31 homozygotes. There are 2,754 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0048 ( 2 hom., 139 hem., cov: 23)
Exomes 𝑓: 0.0077 ( 29 hom. 2615 hem. )
Consequence
C1GALT1C1
NM_001011551.3 missense
NM_001011551.3 missense
Scores
2
6
8
Clinical Significance
Conservation
PhyloP100: 4.70
Genes affected
C1GALT1C1 (HGNC:24338): (C1GALT1 specific chaperone 1) This gene encodes a type II transmembrane protein that is similar to the core 1 beta1,3-galactosyltransferase 1, which catalyzes the synthesis of the core-1 structure, also known as Thomsen-Friedenreich antigen, on O-linked glycans. This gene product lacks the galactosyltransferase activity itself, but instead acts as a molecular chaperone required for the folding, stability and full activity of the core 1 beta1,3-galactosyltransferase 1. Mutations in this gene have been associated with Tn syndrome. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.008848816).
BP6
Variant X-120626865-C-T is Benign according to our data. Variant chrX-120626865-C-T is described in ClinVar as [Benign]. Clinvar id is 791741.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-120626865-C-T is described in Lovd as [Benign].
BS2
High Homozygotes in GnomAd4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
C1GALT1C1 | NM_001011551.3 | c.302G>A | p.Ser101Asn | missense_variant | 2/2 | ENST00000304661.6 | |
C1GALT1C1 | NM_152692.5 | c.302G>A | p.Ser101Asn | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
C1GALT1C1 | ENST00000304661.6 | c.302G>A | p.Ser101Asn | missense_variant | 2/2 | 1 | NM_001011551.3 | P1 | |
C1GALT1C1 | ENST00000371313.2 | c.302G>A | p.Ser101Asn | missense_variant | 3/3 | 1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00478 AC: 535AN: 111834Hom.: 2 Cov.: 23 AF XY: 0.00409 AC XY: 139AN XY: 34008
GnomAD3 genomes
AF:
AC:
535
AN:
111834
Hom.:
Cov.:
23
AF XY:
AC XY:
139
AN XY:
34008
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00422 AC: 771AN: 182742Hom.: 1 AF XY: 0.00428 AC XY: 288AN XY: 67270
GnomAD3 exomes
AF:
AC:
771
AN:
182742
Hom.:
AF XY:
AC XY:
288
AN XY:
67270
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00765 AC: 8402AN: 1097921Hom.: 29 Cov.: 32 AF XY: 0.00720 AC XY: 2615AN XY: 363309
GnomAD4 exome
AF:
AC:
8402
AN:
1097921
Hom.:
Cov.:
32
AF XY:
AC XY:
2615
AN XY:
363309
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00478 AC: 535AN: 111889Hom.: 2 Cov.: 23 AF XY: 0.00408 AC XY: 139AN XY: 34073
GnomAD4 genome
AF:
AC:
535
AN:
111889
Hom.:
Cov.:
23
AF XY:
AC XY:
139
AN XY:
34073
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
39
ALSPAC
AF:
AC:
30
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
57
ExAC
AF:
AC:
517
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Polyagglutinable erythrocyte syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
C1GALT1C1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 07, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
D;D
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D
REVEL
Benign
Sift
Benign
D;D
Sift4G
Uncertain
T;T
Polyphen
B;B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at